| Symbol | NTHI |
|---|---|
| Name | NEONC TECHNOLOGIES HOLDINGS, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | 23975 PARK SORRENTO,SUITE 205, CALABASAS, California, 91302, United States |
| Telephone | +1 818-570-6844 |
| Fax | — |
| — | |
| Website | https://neonc.com/ |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001979414 |
| Description | Our company (NAS-ONC, Inc.) was formed in 2008, devoted to developing new drugs with new delivery modes. As a clinical-stage biopharmaceutical company, we have focused on establishing treatments for intracranial malignancies, i.e., aggressive cancers located in the brain. These cancer types include primary brain cancers, such as glioblastoma, and secondary brain cancers, that have arrived through metastatic spread from other cancers throughout the body, such as melanoma or breast and lung cancer. Additional info from NASDAQ: |
New Form 8-K/A - NEONC TECHNOLOGIES HOLDINGS, INC. <b>Filed:</b> 2026-08-21 <b>AccNo:</b> 0001829126-26-009220 <b>Size:</b> 196 KB <br />Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Read moreNew Form 4/A - NEONC TECHNOLOGIES HOLDINGS, INC. <b>Filed:</b> 2026-08-20 <b>AccNo:</b> 0001213900-26-092276 <b>Size:</b> 15 KB
Read more(99% Neutral) NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) Announces Regulatory Update
Read moreCHEN THOMAS C 🟢 acquired 36.3K shares of NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) at $4.04 Transaction Date: Apr 09, 2026 | Filing ID: 091231
Read moreHeshmatpour Amir F 🟢 acquired 9.0K shares of NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) at $5.54 Transaction Date: Aug 18, 2026 | Filing ID: 091150
Read moreHeshmatpour Amir F 🟢 acquired 15.0K shares of NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) at $4.37 Transaction Date: Aug 14, 2026 | Filing ID: 090894
Read moreNTHI’s Nasdaq Advantage Takes on New Meaning After Its Breakthrough Phase 2a Results
Read more(85% Positive) NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) Provides Update on trial for recurrent IDH1 mutant high-grade glioma
Read moreThe Nose Knows: Why NeOnc’s Patent Portfolio Could Make NTHI More Than a One-Drug Biotech
Read more